Skip to content
Disclosery

EXANE DERIVATIVES: TBBK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on TBBK, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4,286 TBBK shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4,286 shares
    Change vs previous 13F -530 shares

    0.05% of the 13F portfolio, value $83,653.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 4,816 shares
    Change vs previous 13F -4 shares

    0.04% of the 13F portfolio, value $136,438.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 4,820 shares
    Change vs previous 13F -2,785 shares

    0.03% of the 13F portfolio, value $121,998.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 7,605 shares
    Change vs previous 13F +1,294 shares

    0.05% of the 13F portfolio, value $193,554.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 6,311 shares
    Change vs previous 13F +2,845 shares

    0.03% of the 13F portfolio, value $142,884.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,466 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $71,818.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).